Home
Institutions
Researchers
Rankings
Services
Login
Register
Journals
Journals published in
Ali Ismail Al-Gareeb
All journals
Papers in
Inflammopharmacology
25 papers
SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin: TN Almanaa et al.
2026
Cited by 3
Link
Authors
Ali Ismail Al-Gareeb
Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer’s disease treatment
2026
Cited by 20
Link
Authors
Ali Ismail Al-Gareeb
Paracetamol: The potential therapeutic pathways defining its clinical use
2025
Cited by 24
Link
Authors
Ali Ismail Al-Gareeb
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer’s disease
2025
Cited by 18
Link
Authors
Ghassan Mohammad Sulaiman
Ali Ismail Al-Gareeb
Targeting the awry Aβ pathway in Alzheimer’s disease: hype and hurdles
2025
Cited by 8
Link
Authors
Ghassan Mohammad Sulaiman
Ali Ismail Al-Gareeb
Atheroprotective role of vinpocetine: an old drug with new indication
2024
Cited by 13
Link
Authors
Ali Ismail Al-Gareeb
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
2023
Cited by 20
Link
Authors
Ali Ismail Al-Gareeb
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
2023
Cited by 44
Link
Authors
Ali Ismail Al-Gareeb
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
2023
Cited by 49
Link
Authors
Ali Ismail Al-Gareeb
The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
2023
Cited by 54
Link
Authors
Ali Ismail Al-Gareeb
Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
2023
Cited by 85
Link
Authors
Ali Ismail Al-Gareeb
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
2023
Cited by 121
Link
Authors
Ali Ismail Al-Gareeb
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
2022
Cited by 47
Link
Authors
Ali Ismail Al-Gareeb
Benzodiazepines in Alzheimer's disease: beneficial or detrimental effects
2022
Cited by 54
Link
Authors
Ali Ismail Al-Gareeb
The effect of ramatroban on cytokine and thrombotic storms in Covid-19
2022
Cited by 12
Link
Authors
Ali Ismail Al-Gareeb
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection
2022
Cited by 14
Link
Authors
Ali Ismail Al-Gareeb
The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument
2022
Cited by 16
Link
Authors
Ali Ismail Al-Gareeb
Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?
2022
Cited by 31
Link
Authors
Ali Ismail Al-Gareeb
Potential role of lipoxin in the management of COVID-19: a narrative review
2022
Cited by 42
Link
Authors
Ali Ismail Al-Gareeb
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective
2022
Cited by 47
Link
Authors
Ali Ismail Al-Gareeb
The role of berberine in Covid-19: potential adjunct therapy
2022
Cited by 62
Link
Authors
Ali Ismail Al-Gareeb
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
2022
Cited by 77
Link
Authors
Ali Ismail Al-Gareeb
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
2022
Cited by 79
Link
Authors
Ali Ismail Al-Gareeb
COVID-19 and corticosteroids: a narrative review
2022
Cited by 103
Link
Authors
Ali Ismail Al-Gareeb
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
2022
Cited by 102
Link
Authors
Ali Ismail Al-Gareeb